COMMUNIQUÉS West-GlobeNewswire

NeuroSearch and Teva Pharmaceutical International enter into agreement on outstanding obligations
16/05/2018
Announcement 16 May 2018 NeuroSearch has today entered into an agreement with, among others, Teva Pharmaceutical International GmbH (Teva), to release Teva from all outstanding obligations pursuant to the agreement from [...]
HEALTH FOUNDATION OF SOUTH FLORIDA AWARDS GRANTS TO FIVE LOCAL ORGANIZATIONS TOTALING $458,824
16/05/2018
The combined impact of the funding is expected to reach and improve health for thousands of residents MIAMI,FL-, May 16, 2018 (GLOBE NEWSWIRE) -- Health Foundation of South Florida’s Board of Directors recently approved [...]
CROSSJECT : Point d'activité mai 2018
16/05/2018
Communiqué de Presse Point d'activité mai 2018 Nouvelle étape dans l'industrialisation Négociations commerciales en bonne voie Confirmation de l'objectif de dépôts de demande d'AMM [1] Dijon, le 16 mai 2018 CROSSJECT ( [...]
Cesca Prices $5.5 Million Public Offering
16/05/2018
RANCHO CORDOVA, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced the [...]
Notification from Oasmia Pharmaceutical
16/05/2018
Oasmia Pharmaceutical AB (publ) hereby notify that the Company, Arwidsro Investment and MGC Capital have agreed to extend the payment of the loan, which was communicated January 2 nd until September 30 th . The reason [...]
Bavarian Nordic to Host First Quarter 2018 Results Conference Call
16/05/2018
COPENHAGEN, Denmark - May 16 , 201 8 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) will announce its 2018 first quarter results on Thursday, May 24, 2018. The management of Bavarian Nordic will host a conference call at [...]
Theratechnologies Provides Update on Trogarzo™ (Ibalizumab-Uiyk) Injection Prescriptions and Reimbursement Status
16/05/2018
MONTREAL, May 16, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH ) today disclosed, during its annual meeting, information on the number of scripts and reimbursement coverage for Trogarzo™ in the United States [...]
Theratechnologies fournit une mise à jour quant aux prescriptions et au remboursement de Trogarzo(MC) (ibalizumab-uiyk) injection
16/05/2018
MONTRÉAL, 16 mai 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH ) a fait part aujourd’hui, lors de l’assemblée annuelle des actionnaires, d’informations relatives au nombre de prescriptions et au remboursement [...]
Announcements In Conjunction With Theratechnologies Annual Meeting
16/05/2018
MONTREAL, May 16, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH ) today held its annual meeting of shareholders. As part of the meeting, shareholders proceeded to elect the Company’s Board of Directors for a [...]
Annonces en marge de l’assemblée annuelle de Theratechnologies
16/05/2018
MONTRÉAL, 16 mai 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (TSX: TH ) a tenu aujourd’hui son assemblée annuelle des actionnaires. Au cours de l’assemblée, les actionnaires ont élu les membres du conseil d’ [...]
Kommuniké från årsstämman i LIDDS
16/05/2018
Den 16 maj 2018 hölls årsstämma i LIDDS AB (publ). Nedan följer sammanfattning av de beslut som fattades. Beslut fattades med erforderlig majoritet . Vid stämman var 2 418 048 (11,1 %) av totalt 21 871 188 aktier [...]
Medtronic Begins U.S. Study of Drug-Eluting Stents to Evaluate Treatment of Bifurcation Lesions in Patients with Coronary Artery Disease
16/05/2018
Medtronic Received IDE Approval from FDA to Generate Clinical Evidence with Resolute Onyx DES to Support Future Application for Expanded Indication in U.S. DUBLIN - May 16, 2018 - Medtronic plc (NYSE: MDT) today [...]
Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä
16/05/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 16 MAY 2018 at 16.40 EEST Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä Orion Corporation has received the following disclosure under Market Abuse [...]
Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä
16/05/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 16 MAY 2018 at 16.30 EEST Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä Orion Corporation has received the following disclosure under Market Abuse [...]
Scythian Biosciences Announces ColCanna SAS’ Receipt of Licence to Cultivate and Import CBD into Colombia
16/05/2018
– ENTERS INTO EXCLUSIVE SUPPLY AGREEMENT WITH APHRIA – – COLCANNA TO BE FIRST TO MARKET WITH APHRIA’S PHARMACEUTICAL GRADE CBD OIL IN COLOMBIA – TORONTO, May 16, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the [...]
Innovate Biopharmaceuticals Reports First Quarter 2018 Key Financial and Corporate Highlights
16/05/2018
Further data on larazotide’s mechanism of action, dose response and pharmacology expected at DDW (June 2-5) in Washington D.C. Addition to senior management of June Almenoff, M.D., PhD. as COO and CMO (former principal [...]
Sienna Biopharmaceuticals to Present SNA-125 Pre-Clinical Psoriasis Data as Late-Breaker at the International Investigative Dermatology Congress
16/05/2018
WESTLAKE VILLAGE, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA ) today announced that pre-clinical data from the Company’s topical product candidate SNA-125, a novel, selective [...]
Crisp Regional Health, Inc. Selects Cerner Integrated EHR to Support Improved Patient Care
16/05/2018
CORDELE, Ga., May 16, 2018 (GLOBE NEWSWIRE) -- Crisp Regional Health, Inc. has selected Cerner, a global leader in health care technology, to implement a new integrated electronic health record (EHR) and revenue cycle [...]
Zealand Pharma - Interim report for the first quarter of 2018
16/05/2018
Company announcement - No. 14 / 2018 Zealand Pharma - Interim report for the first quarter of 2018 Copenhagen, May 16, 2018 - Zealand Pharma A/S ("Zealand") (Company reg. No. 20 04 50 78), the Copenhagen-based company [...]

Pages